Volcano Corporation Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013
5/23/2013 6:47:37 AM
More...
|
Volcano Corporation Announces Presentations at Upcoming Investor Conferences
5/22/2013 6:39:00 AM
More...
|
Volcano Corporation Release: Verrata™ Pressure Guide Wire and iFR® (Instant Wave-Free Ratio™) Software Modality Will be on Display at EuroPCR 2013
5/21/2013 6:47:30 AM
More...
|
Volcano Corporation to Highlight its Physiology Expansion Efforts at EuroPCR 2013
5/21/2013 6:37:38 AM
More...
|
Volcano Corporation Announces First Quarter Results
5/3/2013 7:22:05 AM
More...
|
Volcano Corporation Schedules First Quarter Conference Call, Webcast
4/22/2013 6:52:03 AM
More...
|
Volcano Corporation Announces Launch of Valet® Microcatheter in the United States and Europe
3/14/2013 10:16:57 AM
More...
|
Volcano Corporation Announces Presentations at Upcoming Investor Conferences
3/4/2013 9:59:08 AM
More...
|
Volcano Corporation Announces Webcast of March Seventh Analyst Day
2/26/2013 9:46:06 AM
More...
|
Volcano Corporation Provides Additional Guidance For 2013
2/22/2013 8:54:14 AM
More...
|
|